Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 49

Sort by

Sort Order Select

Journal Articles

RAR Gamma Activation Sensitizes Human Myeloma Cells to Carfilzomib Treatment through OAS-RNase L Innate Immune Pathway

Qiang Wang, Zhijuan Lin, MD, Qing Yi, MD PhD

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-133970

Published: 2020

Journal Articles

Development of an Immunotherapeutic Monoclonal Antibody Recognizing DKK1-HLA-A2 Complex to Treat Human Hematologic Malignancies

Jianfei Qian, PhD, Qiang Wang, PhD, Lintao Liu, PhD, Enguang Bi, PhD, Xingzhe Ma, PhD, Pan Su, PhD, Maojie Yang, Qing Yi, MD PhD

Blood (2019) 134 (Supplement_1): 5551.

https://doi.org/10.1182/blood-2019-123541

Published: 2019

Journal Articles

The Novel Subtype-Selective Histone Deacetylase (HDAC) Inhibitor, Chidamide, Exerts Dual Anti-Myeloma and Bone Protective Effect in Vitro and In Vivo

Jingsong He, MD, Qingxiao Chen, MS, Yang Yang, MD, Yi Li, MD, Li Yang, MD, He Huang, MD PhD, Qing Yi, MD PhD, Zhen Cai, MD PhD

Blood (2017) 130 (Supplement 1): 5392.

https://doi.org/10.1182/blood.V130.Suppl_1.5392.5392

Published: 2017

Journal Articles

C-Reactive Protein Promotes Bone Destruction in Human Myeloma By Stimulating Myeloma Cell Production of Osteolytic Cytokines Via the CD32/FcγRII-p38MAPK-Twist Axis

Jing Yang, PhD, Zhiqiang Liu, PhD, Huan Liu, PhD, Jin He, Jianling Yang, PhD, Pei Lin, MDDM,MDC, Qiang WANG, PhD, Juan Du, PhD MD, Wencai Ma, Richard E Davis, BSPharm, MS, Robert Z. Orlowski, MD PhD, Jian Hou, MD, Qing Yi, MD PhD

Blood (2017) 130 (Supplement 1): 3043.

https://doi.org/10.1182/blood.V130.Suppl_1.3043.3043

Published: 2017

Journal Articles

NEDD4-1 Modulates the Resistance of Multiple Myeloma to Bortezomib Via PTEN/PI3K/Akt Signaling Pathway

Xi Huang, Zhang En Fan, Qingxiao Chen, MS, Haimeng Yan, Xu Ruyi, Xinling Liu, Huiyao Gu, Jingsong He, MD, He Huang, MD PhD, Qing Yi, MD PhD, Zhen Cai, MD PhD

Blood (2017) 130 (Supplement 1): 1787.

https://doi.org/10.1182/blood.V130.Suppl_1.1787.1787

Published: 2017

Journal Articles

Targeting the MALAT1/PARP1/LIG3 Complex Induces DNA Damage and Apoptosis in Multiple Myeloma Mouse Models

Yi Hu, Jing Fang, Hua Fang, Chen Li, Shuang Liu, Sarah L. Ondrejka, MD, Zihua Gong, Jaroslaw P. Maciejewski, PhD MD FACP, Frederic J. Reu, MD, Qing Yi, MD PhD, Jianjun Zhao, MD

Blood (2017) 130 (Supplement 1): 1829.

https://doi.org/10.1182/blood.V130.Suppl_1.1829.1829

Published: 2017

Journal Articles

IL-32γ Induces M2 Macrophage Polarization with Enhanced Ability of Macrophage-Mediated Drug Resistance in Myeloma Cells through STAT3 and NF-κB Activation

Haimeng Yan, Xuanru Lin, MD, Xi Huang, MD, Zhang En Fan, Donghua He, Xu Ruyi, Huiyao Gu, Yi Li, MD, Jingsong He, MD, Qing Yi, MD PhD, Zhen Cai, MD PhD

Blood (2017) 130 (Supplement 1): 1781.

https://doi.org/10.1182/blood.V130.Suppl_1.1781.1781

Published: 2017

Journal Articles

AMPK Expressed By Multiple Myeloma Cells Inhibited Metformin-Induced Myeloma Cells Proliferation

Fuming Zi, PhD, Jingsong He, Enfan Zhang, M.MD, Yang Yang, PhD, He Huang, MD PhD, Qing Yi, MD PhD, Zhen Cai, MD PhD

Blood (2016) 128 (22): 5703.

https://doi.org/10.1182/blood.V128.22.5703.5703

Published: 2016

Journal Articles

Chemokines CCL14 and CCL3 Facilitate Monocytes/Macrophage Infiltration in Multiple Myeloma Bone Marrow

Yi Li, M.MD, Yuhuan Zheng, PhD, Li Yang, M.MD, Qiang Wang, PhD, Enguang Bi, PhD, Tianshu Li, PhD, Yong Lu, PhD, Jianfei Qian, PhD, Mingjun Zhang, PhD, Maojie Yang, MS, Qing Yi, MD PhD, Zhen Cai, MDPhD

Blood (2014) 124 (21): 3380.

https://doi.org/10.1182/blood.V124.21.3380.3380

Published: 2014

Journal Articles

Macrophage Migration Inhibitory Factor Regulates Multiple Myeloma Bone Marrow Homing

Yuhuan Zheng, PhD, Qiang Wang, PhD, Jianfei Qian, PhD, Yi Li, MD, Yong Lu, PhD, Enguang Bi, PhD, Mingjun Zhang, PhD, Tianshu Li, PhD, Maojie Yang, MS, Yu Wu, MD PhD, Frederic J. Reu, MD, Zhen Cai, Qing Yi, MD PhD

Blood (2014) 124 (21): 2015.

https://doi.org/10.1182/blood.V124.21.2015.2015

Published: 2014

Journal Articles

The Expression Of CD200 As a Prognostic Factor In Newly Diagnosed Multiple Myeloma

Yi Li, M.Med, Wenjun Wu, M.Med, Jingsong He, MD, PhD, Xiaoyan Han, M.Med, Gaofeng Zheng, M.Med, Fuming Zi, M.Med, Li Yang, M.Med, Cai Wu, M.Med, Donghua He, PhD, Yi Zhao, PhD, Yang Yang, PhD, Lijuan Wang, PhD, Xiujin Ye, M.D. Ph.D., He Huang, MD, PhD., Qing Yi, MD, PhD, Zhen Cai, MD, PhD

Blood (2013) 122 (21): 3082.

https://doi.org/10.1182/blood.V122.21.3082.3082

Published: 2013

Journal Articles

Fibroblast Activation Protein Protects Bortezomib Induced Apoptosis In Multiple Myeloma Cells Through β-Catenin Signaling Pathway

Fuming Zi, M.Med, Jingsong He, MD, PhD, Donghua He, PhD, Yi Li, M.Med, Li Yang, M.Med, Lijuan Wang, PhD, Yang Yang, PhD, Yi Zhao, PhD, Wenjun Wu, M.Med, He Huang, MD, PhD., Qing Yi, MD, PhD, Zhen Cai, MD, PhD

Blood (2013) 122 (21): 3083.

https://doi.org/10.1182/blood.V122.21.3083.3083

Published: 2013

Journal Articles

Activation Of Autophagy By Bone Marrow Adipocytes Protects Myeloma Cells From Chemotherapy-Induced Apoptosis

Jing Yang, PhD, Jingda Xu, PhD, Zhiqiang Liu, PhD, Jin He, Huan Liu, Pei Lin, MD, Robert Z. Orlowski, M.D., Ph.D, Larry W. Kwak, MD, PhD, Qing Yi, MD, PhD

Blood (2013) 122 (21): 1915.

https://doi.org/10.1182/blood.V122.21.1915.1915

Published: 2013

Journal Articles

Anti-β2 Microglobulin Monoclonal Antibodies Overcome Bortezomib-Induced Drug Resistance In Multiple Myeloma By Inhibition Of Autophagy

Mingjun Zhang, PhD, Jin He, Yong Lu, PhD, Yuhuan Zheng, PhD, Bangxing Hong, MD, PhD, Haiyan Li, MD, PhD, Zhiqiang Liu, PhD, Jingda Xu, PhD, Huan Liu, Jianfei Qian, PhD, Qing Yi, MD, PhD, Jing Yang, PhD

Blood (2013) 122 (21): 929.

https://doi.org/10.1182/blood.V122.21.929.929

Published: 2013

Journal Articles

Myeloma Cells Exhibit Inhibitory Effect On Osteoclastogenesis

Zhiqiang Liu, PhD, Yuhuan Zheng, PhD, Haiyan Li, MD, PhD, Jingda Xu, PhD, Jin He, Eryong Huang, Yong Lu, PhD, Jungsun Park, Bangxing Hong, PhD, Mingjun Zhang, PhD, Jianfei Qian, PhD, Pei Lin, MD, Larry W. Kwak, MD, PhD, Qing Yi, MD, PhD, Jing Yang, PhD

Blood (2012) 120 (21): 439.

https://doi.org/10.1182/blood.V120.21.439.439

Published: 2012

Journal Articles

P38 MAPK Activity in Myeloma Cells Regulates Osteoclast and Osteoblast Activity and Induces Bone Destruction in Vivo

Jin He, PhD, Zhiqiang Liu, PhD, Yuhuan Zheng, PhD, Jianfei Qian, PhD, Haiyan Li, MD, PhD, Yong Lu, PhD, Jingda Xu, PhD, Bangxing Hong, PhD, Mingjun Zhang, PhD, Pei Lin, MD, Zhen Cai, Robert Z. Orlowski, M.D., Ph.D., Larry W Kwak, MD, PhD, Qing Yi, MD, PhD, Jing Yang, PhD

Blood (2012) 120 (21): 566.

https://doi.org/10.1182/blood.V120.21.566.566

Published: 2012

Journal Articles

Expression of B7-H1 in Mantle Cell Lymphoma Leads to Inhibition of T Cell Response to Tumor Cells

Lijuan Wang, MD, PhD, Jianfei Qian, PhD, Yong Lu, PhD, Haiyan Li, MD, PhD, Sungyoul Hong, PhD, Hanying Bao, MD, PhD, Donghua He, MD, PhD, Zhiqiang Liu, PhD, Yuhuan Zheng, PhD, Jin He, PhD, Yongsheng Lan, PhD, Yi Li, MD, Sattva Neelapu, MD, Jing Yang, PhD, Michael Wang, MD, Cai Zhen, MD, PhD, Qing Yi, MD, PhD

Blood (2011) 118 (21): 2643.

https://doi.org/10.1182/blood.V118.21.2643.2643

Published: 2011

Journal Articles

Carfilzomib, An Irreversible Proteasome Inhibitor, Induces Long-Term Growth Inhibition of Mantle Cell Lymphoma In Vivo,

Liang Zhang, MD, PhD, Jianfei Qian, PhD, Zhishuo Ou, MD, Luhong Sun, MD, PhD, Kejie Zhang, MD, PhD, Lan V Pham, PhD, Christopher J Kirk, PhD, Richard J. Ford, MD, PhD, Qing Yi, MD, PhD, Michael Wang, MD

Blood (2011) 118 (21): 3740.

https://doi.org/10.1182/blood.V118.21.3740.3740

Published: 2011

Journal Articles

Reciprocal Interaction Between Osteoclasts and T Cells: Osteoclasts Inhibit T Cell Proliferation by IDO Produced in Response to T Cell-Derived IFN-γ and CD40 Ligand

Haiyan Li, MD, PhD, Yong Lu, PhD, Sungyoul Hong, PhD, Jianfei Qian, PhD, Zhiqiang Liu, Yuhuan Zheng, PhD, Yongsheng Lan, Jin He, Jing Yang, PhD, Qing Yi, MD, PhD

Blood (2011) 118 (21): 694.

https://doi.org/10.1182/blood.V118.21.694.694

Published: 2011

Journal Articles

P/E Selectins and Their Ligand PSGL-1 Are Crucial for Macrophage-Mediated Multiple Myeloma Chemoresistance

Yuhuan Zheng, Jing Yang, PhD, Jianfei Qian, Shino Hanabuchi, Zhiqiang Liu, Yong Lu, PhD, Jin He, Haiyan Li, MD, PhD, Jatin J Shah, MD, Yongsheng Lan, Qing Yi, MD, PhD

Blood (2011) 118 (21): 130.

https://doi.org/10.1182/blood.V118.21.130.130

Published: 2011

NARROW

RAR Gamma Activation Sensitizes Human Myeloma Cells to Carfilzomib Treatment through OAS-RNase L Innate Immune Pathway

Development of an Immunotherapeutic Monoclonal Antibody Recognizing DKK1-HLA-A2 Complex to Treat Human Hematologic Malignancies

The Novel Subtype-Selective Histone Deacetylase (HDAC) Inhibitor, Chidamide, Exerts Dual Anti-Myeloma and Bone Protective Effect in Vitro and In Vivo

C-Reactive Protein Promotes Bone Destruction in Human Myeloma By Stimulating Myeloma Cell Production of Osteolytic Cytokines Via the CD32/FcγRII-p38MAPK-Twist Axis

NEDD4-1 Modulates the Resistance of Multiple Myeloma to Bortezomib Via PTEN/PI3K/Akt Signaling Pathway

Targeting the MALAT1/PARP1/LIG3 Complex Induces DNA Damage and Apoptosis in Multiple Myeloma Mouse Models

IL-32γ Induces M2 Macrophage Polarization with Enhanced Ability of Macrophage-Mediated Drug Resistance in Myeloma Cells through STAT3 and NF-κB Activation

AMPK Expressed By Multiple Myeloma Cells Inhibited Metformin-Induced Myeloma Cells Proliferation

Chemokines CCL14 and CCL3 Facilitate Monocytes/Macrophage Infiltration in Multiple Myeloma Bone Marrow

Macrophage Migration Inhibitory Factor Regulates Multiple Myeloma Bone Marrow Homing

The Expression Of CD200 As a Prognostic Factor In Newly Diagnosed Multiple Myeloma

Fibroblast Activation Protein Protects Bortezomib Induced Apoptosis In Multiple Myeloma Cells Through β-Catenin Signaling Pathway

Activation Of Autophagy By Bone Marrow Adipocytes Protects Myeloma Cells From Chemotherapy-Induced Apoptosis

Anti-β2 Microglobulin Monoclonal Antibodies Overcome Bortezomib-Induced Drug Resistance In Multiple Myeloma By Inhibition Of Autophagy

Myeloma Cells Exhibit Inhibitory Effect On Osteoclastogenesis

P38 MAPK Activity in Myeloma Cells Regulates Osteoclast and Osteoblast Activity and Induces Bone Destruction in Vivo

Expression of B7-H1 in Mantle Cell Lymphoma Leads to Inhibition of T Cell Response to Tumor Cells

Carfilzomib, An Irreversible Proteasome Inhibitor, Induces Long-Term Growth Inhibition of Mantle Cell Lymphoma In Vivo,

Reciprocal Interaction Between Osteoclasts and T Cells: Osteoclasts Inhibit T Cell Proliferation by IDO Produced in Response to T Cell-Derived IFN-γ and CD40 Ligand

P/E Selectins and Their Ligand PSGL-1 Are Crucial for Macrophage-Mediated Multiple Myeloma Chemoresistance

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only